| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |